Details
Livostor Indications
- reduce the risk of fatal ischemic heart disease and manifestations of non-fatal myocardial infarction;
- reduce the risk of stroke;
- reduce the risk of angina and the need for revascularization procedures performance.
Patients with symptomatic coronary disease, atorvastatin is indicated for:
- reduce the risk of non-fatal myocardial infarction;
- reduce the risk of fatal and nonfatal stroke;
- reduce the risk during the revascularization procedure;
- reduce the risk of hospitalization due to congestive heart failure;
- reduce the risk of angina pectoris.
Children (10-17 years).
Livostor used as an adjunct to diet to reduce total cholesterol, LDL cholesterol, apolipoprotein B boys and girls in postmenarhialny period with heterozygous familial hypercholesterolemia, even when subject to an adequate diet if
Administration
Before starting therapy with Livostoro should determine the level of cholesterol in the blood against the backdrop of an appropriate diet, exercise, and assign actions to reduce body weight in obese patients, and conduct treatment of other diseases. During treatment, patients should adhere to a standard cholesterol-lowering diet. The drug is prescribed in a dose of 10-80 mg 1 time a day, every day, at any time of the day, regardless of meals. Starting and maintenance doses can be individualized according to the baseline LDL levels, tasks, and the effectiveness of therapy. After 2-4 weeks of starting treatment and / or Livostora dose adjustment is necessary to determine the level of lipoproteins and, accordingly, to carry out the dose adjustment.
Primary hypercholesterolaemia and combined (mixed) hyperlipidemia. In most cases sufficient to use the drug in a dose of one 10 mg once a day, daily. Treatment effect appears after 2 weeks, reaching a maximum of 4 weeks and is maintained during long-term treatment.
Contradiction
Hypersensitivity to the drug, active liver disease or transaminase indefinitely persistent increase in activity, three times higher than normal.
